Welcome to LookChem.com Sign In|Join Free
  • or
Pyrazinecarboxylic acid, 3,4-dihydro-3-oxo-5-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

41270-60-4

Post Buying Request

41270-60-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41270-60-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 41270-60-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,7 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 41270-60:
(7*4)+(6*1)+(5*2)+(4*7)+(3*0)+(2*6)+(1*0)=84
84 % 10 = 4
So 41270-60-4 is a valid CAS Registry Number.

41270-60-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-oxo-5-phenyl-3,4-dihydro-pyrazine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3-Hydroxy-5-phenyl-pyrazine-2-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41270-60-4 SDS

41270-60-4Downstream Products

41270-60-4Relevant academic research and scientific papers

INHIBITORS OF FATTY ACID BINDING PROTEIN

-

, (2012/05/21)

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (“FABP”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 41270-60-4